Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Sign Up To Get Our Instant Alerts!
- UCASU to Acquire 10,000 Sqft Cannabis Property and Build 5,000 Sqft More 558 views
- UC Asset’s new $3M cannabis property acquisition includes protection for existing shareholders 364 views
- ZICIX+CTIP-FII SIGNS CONTRACT WITH IFCI TO DEVELOP $20 MILLION SENIOR CITIZENS RESIDENCE PROJECT IN NEWARK, NEW JERSEY 65 views
- Kimberly Goldwin Poised to Become Next President of ABC News 49 views
- JPMorgan Bringing Back Employees to Work From Office 48 views